• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 血清流行率及青年感染者的决定因素:一项基于人群的血清流行病学研究。

SARS-CoV-2 seroprevalence and determinants of infection in young adults: a population-based seroepidemiological study.

机构信息

Institute of Medical Sociology, Centre for Health and Society, Medical Faculty and University Hospital, Heinrich Heine University, Düsseldorf, Germany.

Central Institute for Clinical Chemistry and Laboratory Diagnostics, Heinrich Heine University, University Hospital, Düsseldorf, Germany.

出版信息

Public Health. 2022 Jun;207:54-61. doi: 10.1016/j.puhe.2022.03.009. Epub 2022 Mar 23.

DOI:10.1016/j.puhe.2022.03.009
PMID:35490440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8940565/
Abstract

OBJECTIVES

Most SARS-CoV-2 seroprevalence studies have focussed on adults and high-risk populations, and little is known about young adults. The objective of the present study was to provide evidence on the SARS-CoV-2 seroprevalence among young adults in Germany and to explore determinants associated with seropositivity in general and, specifically, with previously undetected infections.

STUDY DESIGN

This was a population-based SARS-CoV-2 seroprevalence study.

METHODS

In November 2020, a population-based study on SARS-CoV-2 seroprevalence in young adults (aged 18-30 years) was conducted in a large German city. Serum samples were obtained to analyse the SARS-CoV-2 antibody status using the Elecsys Anti-SARS-CoV-2 immunoassay. Descriptive statistics and odds ratios (ORs) of seropositivity and of previously undetected infections in relation to different determinants were calculated.

RESULTS

Among 2186 participants, SARS-CoV-2 antibodies were detected in 72 individuals, equalling a test performance-adjusted seroprevalence of 3.1% (95% confidence interval [CI]: 2.4-4.0). Based on reported COVID-19 cases to the public health authority, a moderate underascertainment rate of 1.7 was calculated. Seropositivity was higher among individuals who sought COVID-19-related information from social media (OR: 1.83, 95% CI: 1.2-3.1), and undetected COVID-19 infections were more prevalent among men and those not adhering to social distancing.

CONCLUSIONS

The results show a substantial underascertainment of SARS-CoV-2 infections among young adults and indicate that seroprevalence is likely to be much higher than the reported COVID-19 prevalence based on confirmed COVID-19 cases in Germany. Preventive efforts should consider the heterogeneity of risk profiles among the young adult population.

摘要

目的

大多数 SARS-CoV-2 血清流行率研究都集中在成年人和高危人群,而对年轻人知之甚少。本研究的目的是提供德国年轻人中 SARS-CoV-2 血清流行率的证据,并探讨与血清阳性率相关的决定因素,特别是与先前未检测到的感染相关的决定因素。

研究设计

这是一项基于人群的 SARS-CoV-2 血清流行率研究。

方法

2020 年 11 月,在德国一个大城市对年轻人(18-30 岁)进行了一项基于人群的 SARS-CoV-2 血清流行率研究。采集血清样本,使用 Elecsys Anti-SARS-CoV-2 免疫分析检测 SARS-CoV-2 抗体状态。计算了不同因素与血清阳性率和先前未检测到的感染的比值比(OR)。

结果

在 2186 名参与者中,有 72 人检测到 SARS-CoV-2 抗体,经检测性能调整后的血清流行率为 3.1%(95%置信区间[CI]:2.4-4.0)。根据向公共卫生当局报告的 COVID-19 病例,计算出适度的低估率为 1.7。在从社交媒体获取 COVID-19 相关信息的个体中,血清阳性率较高(OR:1.83,95% CI:1.2-3.1),而未检测到的 COVID-19 感染在男性和不遵守社交距离的人群中更为普遍。

结论

研究结果表明,年轻人中 SARS-CoV-2 感染的大量漏诊,表明血清流行率可能远高于德国基于确诊 COVID-19 病例报告的 COVID-19 流行率。预防措施应考虑到年轻人群体风险特征的异质性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6012/8940565/b313f86e8452/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6012/8940565/b313f86e8452/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6012/8940565/b313f86e8452/gr1_lrg.jpg

相似文献

1
SARS-CoV-2 seroprevalence and determinants of infection in young adults: a population-based seroepidemiological study.SARS-CoV-2 血清流行率及青年感染者的决定因素:一项基于人群的血清流行病学研究。
Public Health. 2022 Jun;207:54-61. doi: 10.1016/j.puhe.2022.03.009. Epub 2022 Mar 23.
2
Underascertainment of COVID-19 cases among first responders: a seroepidemiological study.一线工作者中 COVID-19 病例漏报:一项血清流行病学研究。
Occup Med (Lond). 2022 Apr 19;72(3):225-228. doi: 10.1093/occmed/kqab164.
3
Seroprevalence of SARS-CoV-2 specific Immunoglobin G antibodies in rural population of Western Maharashtra, India.印度马哈拉施特拉邦西部地区农村人群中 SARS-CoV-2 特异性免疫球蛋白 G 抗体的血清流行率。
J Glob Health. 2023 Apr 21;13:06011. doi: 10.7189/jogh.13.06011.
4
High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.秘鲁农村地区 2021 年 SARS-CoV-2 血清阳性率高:一项基于人群的横断面研究。
mSphere. 2021 Dec 22;6(6):e0068521. doi: 10.1128/mSphere.00685-21. Epub 2021 Nov 24.
5
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.美国中西部一公立学校系统工作人员中抗 SARS-CoV-2 IgG 抗体的血清阳性率。
PLoS One. 2021 Jun 10;16(6):e0243676. doi: 10.1371/journal.pone.0243676. eCollection 2021.
6
Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.香港 3 波新冠疫情期间不明 SARS-CoV-2 感染的血清流行率。
JAMA Netw Open. 2021 Nov 1;4(11):e2132923. doi: 10.1001/jamanetworkopen.2021.32923.
7
Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study.COVID-19 大流行第一波后法国脆弱人群中抗 SARS-CoV-2 抗体的血清阳性率:一项横断面研究。
BMJ Open. 2021 Nov 23;11(11):e053201. doi: 10.1136/bmjopen-2021-053201.
8
Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.全球 2020 年 1 月至 2022 年 4 月 SARS-CoV-2 血清流行率:基于人群的标准化研究的系统评价和荟萃分析。
PLoS Med. 2022 Nov 10;19(11):e1004107. doi: 10.1371/journal.pmed.1004107. eCollection 2022 Nov.
9
Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.苏格兰对 COVID-19 的强化监测:在疫情第一波期间对 SARS-CoV-2 进行基于人群的血清流行率监测。
Public Health. 2021 Jan;190:132-134. doi: 10.1016/j.puhe.2020.11.014. Epub 2020 Nov 24.
10
Trend in seroprevalence of SARS-CoV-2 (IgG antibody) among tribal-dominated population: Findings from Jharkhand, India.印度恰尔康得邦部落人群中 SARS-CoV-2(IgG 抗体)血清阳性率趋势:来自印度恰尔康得邦的研究结果。
Indian J Med Res. 2022 Aug;156(2):228-239. doi: 10.4103/ijmr.ijmr_3040_21.

引用本文的文献

1
Community case study for surveillance and early case-detection of SARS-CoV-2 infections across high-risk key populations: the Sentinella programme.社区病例研究,用于对高危关键人群中的 SARS-CoV-2 感染进行监测和早期病例发现:哨兵计划。
Front Public Health. 2024 Oct 23;12:1432157. doi: 10.3389/fpubh.2024.1432157. eCollection 2024.
2
Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany-Results from the SeBluCo Study 2020-2022.监测新冠疫情:德国一项针对献血者的大型重复性横断面研究中抗体的流行情况——SeBluCo研究(2020 - 2022年)结果
Pathogens. 2023 Apr 2;12(4):551. doi: 10.3390/pathogens12040551.
3

本文引用的文献

1
Seroepidemiological study on the spread of SARS-CoV-2 in populations in especially affected areas in Germany - Study protocol of the CORONA-MONITORING lokal study.德国特别受影响地区人群中新型冠状病毒传播的血清流行病学研究——CORONA-MONITORING lokal研究方案
J Health Monit. 2020 Nov 18;5(Suppl 5):2-16. doi: 10.25646/7053. eCollection 2020 Nov.
2
High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl.奥地利伊施格尔滑雪胜地儿童和成人中新冠病毒血清阳性率很高。
Commun Med (Lond). 2021;1(1):4. doi: 10.1038/s43856-021-00007-1. Epub 2021 Jun 30.
3
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021.
Nationally representative results on SARS-CoV-2 seroprevalence and testing in Germany at the end of 2020.
2020 年底德国全国范围内关于 SARS-CoV-2 血清流行率和检测的代表性结果。
Sci Rep. 2022 Nov 14;12(1):19492. doi: 10.1038/s41598-022-23821-6.
4
Vaccination strategies when vaccines are scarce: on conflicts between reducing the burden and avoiding the evolution of escape mutants.疫苗短缺时的疫苗接种策略:减少负担与避免逃逸突变体进化之间的冲突。
J R Soc Interface. 2022 Jun;19(191):20220045. doi: 10.1098/rsif.2022.0045. Epub 2022 Jun 29.
2021 年 8 月至 9 月,在德尔塔变异株(B.1.617.2)占主导地位期间,疫苗对向家庭接触者传播 SARS-CoV-2 的有效性,荷兰。
Euro Surveill. 2021 Nov;26(44). doi: 10.2807/1560-7917.ES.2021.26.44.2100977.
4
SARS-CoV-2 IgG seropositivity in a cohort of 449 non-hospitalized individuals during Spanish COVID-19 lockdown.在西班牙 COVID-19 封锁期间,对 449 名非住院个体的队列进行了 SARS-CoV-2 IgG 血清阳性检测。
Sci Rep. 2021 Nov 3;11(1):21612. doi: 10.1038/s41598-021-00990-4.
5
SARS-CoV-2-specific B- and T-cell immunity in a population-based study of young Swedish adults.基于人群的瑞典青年成年人研究中的 SARS-CoV-2 特异性 B 细胞和 T 细胞免疫。
J Allergy Clin Immunol. 2022 Jan;149(1):65-75.e8. doi: 10.1016/j.jaci.2021.10.014. Epub 2021 Oct 23.
6
The kids are not alright: A preliminary report of Post-COVID syndrome in university students.《儿童情况不妙:大学生新冠后遗症的初步报告》。
J Am Coll Health. 2023 Jul;71(5):1367-1373. doi: 10.1080/07448481.2021.1927053. Epub 2021 Jul 9.
7
Social Media Use, Self-Efficacy, Perceived Threat, and Preventive Behavior in Times of COVID-19: Results of a Cross-Sectional Study in Pakistan.新冠疫情期间巴基斯坦的社交媒体使用、自我效能感、感知威胁及预防行为:一项横断面研究的结果
Front Psychol. 2021 Jun 17;12:562042. doi: 10.3389/fpsyg.2021.562042. eCollection 2021.
8
COVID-19 information on social media and preventive behaviors: Managing the pandemic through personal responsibility.社交媒体上的新冠疫情信息与预防行为:通过个人责任应对疫情
Soc Sci Med. 2021 May;277:113928. doi: 10.1016/j.socscimed.2021.113928. Epub 2021 Apr 12.
9
Preliminary evidence on long COVID in children.儿童长期新冠的初步证据。
Acta Paediatr. 2021 Jul;110(7):2208-2211. doi: 10.1111/apa.15870. Epub 2021 Apr 18.
10
Antibody kinetics and clinical course of COVID-19 a prospective observational study.COVID-19 的抗体动力学和临床过程:一项前瞻性观察研究。
PLoS One. 2021 Mar 22;16(3):e0248918. doi: 10.1371/journal.pone.0248918. eCollection 2021.